Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Nihon Chouzai Co ( (JP:3341) ) has shared an announcement.
Nihon Chouzai Co., Ltd. has announced an impairment loss of 2,084 million yen in its Dispensing Pharmacy Business due to a decline in profitability caused by a changing business environment. Consequently, the company has revised its full-year consolidated earnings forecast, reducing the net income attributable to shareholders by 45.9% to 2,000 million yen for the fiscal year ending March 31, 2025.
More about Nihon Chouzai Co
Nihon Chouzai Co., Ltd. operates in the dispensing pharmacy business, focusing on providing pharmaceutical services and products. The company is listed on the Tokyo Stock Exchange Prime Market.
YTD Price Performance: 0.0%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $253.4M
Find detailed analytics on 3341 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue